lirucitinib   Click here for help

GtoPdb Ligand ID: 13747

Synonyms: compound T4-B [US20220106319A1] | GGW-101 | GGW101
Compound class: Synthetic organic
Comment: Lirucitinib is the INN for a Janus tyrosine kinase inhibitor with anti-inflammatory potential. The INN record specifies the (R)-enantiomer of the molecule. The chemical structure is claimed in Felicamed Biotechnology's patent US20220106319A1 [1]. An internet search reveals that lirucitinib was approved in China (by the Ministry of Agriculture and Rural Affairs) in 2024 for veterinary use, to treat pruritic skin diseases in pet dogs. There is no indication that lirucitinib will be tested for use in humans.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 89.29
Molecular weight 335.47
XLogP 2.42
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCS(=N)(=O)C[C@@]1([H])CC[C@@]([H])(CC1)N(C)C2=C3C=CNC3=NC=N2
Isomeric SMILES [H][C@]1(CS(=N)(=O)CC)CC[C@@]([H])(CC1)N(C)C2=NC=NC3=C2C=CN3
InChI InChI=1S/C16H25N5OS/c1-3-23(17,22)10-12-4-6-13(7-5-12)21(2)16-14-8-9-18-15(14)19-11-20-16/h8-9,11-13,17H,3-7,10H2,1-2H3,(H,18,19,20)/t12-,13-,23?
InChI Key CPIJQOJWCQTORE-IRGPHWNRSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel